Back on the Books Initiative Launched to Aid in Rescheduling Cancer Screening Appointments

News
Video

The goal of the initiative is to have cancer screenings that were made in the first half of 2020 and cancelled due to COVID-19 rescheduled to ensure patients are again receiving routine screenings.

The Prevent Cancer Foundation – the only US-based nonprofit organization solely dedicated to cancer prevention and early detection – has launched a new initiative titled, “Back on the Books.”

The goal of the initiative is to have any mammogram, Pap test, colonoscopy, PSA test, lung cancer screening, skin check, or dental appointment that was made during the first half of 2020 and cancelled due to the coronavirus disease 2019 (COVID-19) pandemic rescheduled by patients.

However, the leaders of the initiative also stressed that screening guidelines are never one-size-fits-all, especially during a pandemic. Therefore, patients should consult with their physician and make the best decision for themselves.

“When deciding when to get your routine screening back on the books, you should weigh the potential risk of exposure to the coronavirus against the potential risk of a late or missed cancer diagnosis,” the authors of the initiative wrote. “If you are immunocompromised or at high risk of complications from contracting the virus, it may make sense to wait. Call your health care provider for guidance.”

In an interview with CancerNetwork®, Lisa Berry Edwards, managing editor of external affairs for the Prevent Cancer Foundation, discussed the “Back on the Books” initiative and what patients should be aware of in regard to rescheduling their previously missed cancer screening appointments.

Reference:

Prevent Cancer Foundation. Back on the Books. Prevent Cancer Foundation Website. Published 2020. preventcancer.org/education/back-on-the-books/. Accessed July 30, 2020.

Recent Videos
Trials at scale can be conducted in middle-income, low-middle-income, and even lower-income countries if you organize a trial ecosystem.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
A consolidated database may allow providers to access information on a patient’s prior treatments and genetic abnormalities all in 1 place.
A study presented at ASTRO 2025 evaluated the feasibility of using a unified cancer database to consolidate information gathered across 14 institutions.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Physical therapists may play a key role in patient care before, during, and after treatment for cancer, according to Alison Ankiewicz, PT, DPT.
Related Content